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To study the activity of the epidermal growth factor 
(EGF) receptor during EGF-directed internalization, 
liver epithelial cells were exposed to EGF at 37 “C for 
various periods of time, washed, and homogenized at 
0 “C. EGF receptor autophosphorylation was assessed 
in homogenates using [T-~~P]ATP. Autophosphoryla- 
tion was stimulated 3- to 6-fold in homogenates of cells 
incubated with EGF (100 rig/ml) for 15 min but was at 
or below basal levels in homogenates of cells treated 
with EGF for 2.5-5 min. This was surprising because 
immunoblotting revealed that EGF receptor phospho- 
tyrosine (P-Tyr) content in intact cells was near max- 
imal from 30 s to 5 min after EGF treatment. Excess 
EGF (1 rg/ml), added after homogenization but prior 
to the assay, increased autophosphorylation in homog- 
enates of cells that had not been treated with EGF, but 
failed to increase activity in homogenates of cells 
treated with EGF in culture for 2.5-5 min. Suppres- 
sion of tyrosine phosphorylation of an exogenous ki- 
nase substrate was also observed at times paralleling 
the suppression of EGF receptor autophosphorylation. 
The transient suppression of receptor autophosphor- 
ylation in the cell-free assay was not explained by 
persistent occupation of autophosphorylation sites by 
phosphate added in the intact cells. The sites were 
>80% dephosphorylated during the homogenization. 
Additionally phosphatase inhibition that prevented the 
normal loss of EGF receptor P-Tyr in intact cells at 15 
min did not affect the pattern of early (2.5-5 min) 
suppression and later (15 min) stimulation of auto- 
phosphorylation measured in the cell-free assay. The 
supression was not explained by activation of protein 
kinase C in that depletion of >95% of cellular protein 
kinase C activity by an 18-h incubation of cells with 
10 PM 12-0-tetradecanoylphorbol 13-acetate (TPA) 
did not affect the early suppression of autophosphory- 
lation in EGF-treated cells. Moreover, under the con- 
ditions tested, activation of protein kinase C by short- 
term treatment (0.5-10 min) with TPA or angiotensin 
II did not appreciably alter subsequent autophosphor- 
ylation in the cell-free assay. In contrast, a 30 “C prein- 
cubation of homogenates from cells with suppressed 
EGF receptor autophosphorylation led to the recovery 
of the ability of EGF to stimulate EGF receptor auto- 
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phosphorylation. These results suggest that a rapid 
reversible protein kinase C-independent process pre- 
vents detection of EGF receptor kinase activity during 
an early phase of EGF-dependent receptor internali- 
zation. 
Epidermal growth factor (EGF)’ alters cellular metabolism 
and stimulates cell growth by interacting with a 170,000- 
dalton transmembrane receptor. EGF binding activates the 
intrinsic tyrosine kinase of the receptor’s cytoplasmic domain. 
Current evidence indicates that regulation of EGF receptor 
action may involve not only modulation of the rates of recep- 
tor synthesis and degradation, but also reversible modification 
of the receptor protein (1, 2). For example, EGF promotes 
receptor aggregation and internalization, processes which may 
influence receptor signaling (3-6). Another example is the 
phosphorylation of the EGF receptor on threonine 654 by 
protein kinase C which decreases the affinity of the receptor 
for EGF and, in some cells, decreases EGF receptor tyrosine 
kinase activity as measured in cell-free assays (7-10). Protein 
kinase C also phosphorylates other EGF-R threonine and 
serine residues, but the significance of these modifications is 
unknown (9,11, 12). Thus, hormones and other agents which 
activate protein kinase C may affect EGF/EGF receptor in- 
teractions. Since EGF itself can activate phospholipase C and 
generate diacylglycerol in some cells (13-15), the effect of 
EGF on EGF receptor signal transduction may be more com- 
plex than simple initiation of receptor endocytosis. In A431 
cells, a human tumor cell line which overexpresses the EGF 
receptor, EGF activates protein kinase C, resulting in phos- 
phorylation of EGF receptor threonine 654 (13, 14). Chinkers 
and Garbers (10) demonstrated that EGF treatment of intact 
A431 cells induced a suppression of EGF receptor/kinase 
activity in subsequently solubilized extracts of A431 cell mem- 
branes. Sturani et al. (16) used anti-P-Tyr immunoblotting to 
demonstrate reduced EGF-dependent EGF receptor P-Tyr 
content in intact A431 cells treated with phorbol esters. Each 
group suggested that activation of protein kinase C modulated 
EGF receptor autophosphorylation and kinase activity. 
We have shown previously that EGF stimulates phosphoi- 
nositide hydrolysis in a nontransformed rat liver epithelial 
cell line (15), and in the present report we demonstrate a 
transient suppression of EGF receptor/kinase activity in cell 
extracts, minutes after the addition of EGF to intact cells. 
1 The abbreviations used are: EGF, epidermal growth factor; EGF- 
R, epidermal growth factor receptor; EGF receptor/kinase, epidermal 
growth factor tyrosine kinase; TPA, tetradecanoylphorbol13-acetate; 
P-Tyr, phosphotyrosine; SDS-PAGE, sodium dodecyl sulfate-poly- 
acrylamide gel electrophoresis; PIPES, piperazine-N,N’-bis(2-eth- 
anesulfonic acid); HEPES, 4-(2-hydroxyethyl)-l-piperazineethane- 
sulfonic acid. 
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This raises the possibility of an EGF-stimulated protein ki- 
nase C-mediated feedback inhibition of EGF-dependent ty- 
rosine phosphorylation in these cells. In fact we have obtained 
evidence that activation of protein kinase C inhibits some 
measures of EGF-dependent tyrosine phosphorylation in in- 
tact WB cells.’ However, the suppression of activity detected 
in our cell-free assay was not due to protein kinase C activa- 
tion, since it occurred in cells depleted of protein kinase C. In 
fact, activation of protein kinase C prior to the addition of 
EGF had little effect on autophosphorylation of the EGF 
receptor assayed in cell-free extracts. The data presented in 
this and another recent report (17) suggest that, in a nontrans- 
formed epithelial cell with a normal receptor complement and 
internalization pattern, there are at least four separable stages 
through which the EGF-R tyrosine kinase passes upon the 
binding of EGF. The first stage, kinase activation which 
occurs within seconds of EGF-binding to cell surface receptor, 
is responsible for a large proportion of the cellular protein 
tyrosine phosphorylation (17) and initiates the internalization 
process (1, 2). The second stage is characterized by a confor- 
mation change in the receptor or its association with other 
cellular constituents. This stage, defined by suppressed auto- 
phosphorylation and kinase activity as measured in a cell-free 
assay, occurs within 2-5 min of exposure of the cell to EGF. 
The suppression is not mediated by protein kinase C and 
probably involves only those receptors occupied by EGF. The 
third stage is characterized by re-establishment of detectable 
kinase activity in the internalized receptor pool lo-30 min 
after the initial internalization. During this time period, the 
EGF receptor/kinase is active in cell-free assays, but becomes 
effectively inactive in intact cells as shown by progressive loss 
of receptor P-Tyr content in the intact cell (17). This loss of 
P-Tyr on autophosphorylation sites may be due to sequestra- 
tion of the receptor from cellular ATP pools as the receptor 
moves into complex intracellular vesicles. Last, in the fourth 
stage, transfer of receptors to lysosomes abolishes kinase 
activity, presumably due to receptor degradation. 
EXPERIMENTAL PROCEDURES 
Muterzals-EGF, purified from male mouse salivary glands (18), 
was iodinated with “‘1 (Amersham Corp.) by the chloramine-T 
method (19). [r-“PIATP, IL’ I-protein A, and [“S]methionine were 
purchased from Du Pont-New England Nuclear. Other reagents were 
purchased from Sigma, unless otherwise indicated. - 
Cell Culture-WB-344 cells (20). maintained in Richter’s imnroved 
minimal essential medium supplemented with 10% fetal bovine serum 
and 0.1 pM insulin, were used as confluent cultures of passage 19-25. 
For short-term (up to 2 h) experimental incubations with EGF, the 
culture medium was changed to serum-free Eagle’s minimal essential 
with 20 mM HEPES, pH 7.4, 15-30 min prior to addition of EGF. 
Antibodies and Immunoblotting-Monospecific polyclonal anti- 
phosphotyrosine antibodies were prepared by immunizing rabbits 
with a random co-polymer of phosphotyrosine, glycine, and alanine 
coupled to keyhole limpet hemocyanin (Calbiochem) using l-ethyl-3- 
(3-dimethylaminopropyl) carbodiimide (Calbiochem) as described by 
Kamps and Sefton (21). The injection and affinity purification are 
detailed elsewhere (17). After experimental manipulations, lysates of 
WB cells were prepared and subjected to immunoblotting with the 
affinity purified anti-P-Tyr antisera as described (17). 
Kinase Assays-To assess EGF-R autophosphorylation activity, 
monolayers were washed, scraped into 0.5 ml of cold 10 mM Tris- 
HCl, pH 7.4, 0.25 M sucrose containing 10 pg/ml leupeptin, 20 pg/ml 
phenylmethylsulfonyl fluoride, and 100 KIU/ml aprotinin, and ho- 
mogenized on ice in a glass vessel with 30 strokes of a motor-driven 
Teflon pestle. This resulted in breakage of greater that 95% of the 
cells as assessed by light microscopic examination. Autophosphory- 
lation activity was assessed at 0 “C in 60 ~1 containing 50 mM PIPES, 
pH 7.0,l mM MnCl?, and 0.2 mM sodium vanadate (22). Each reaction 
’ W. R. Huckle, J. R. Hepler, S. G. Rhee, T. K. Harden, and H. S. 
Earp, submitted for publication. 
mixture, containing 20 ~1 (approximately 40 /*g of protein) of homog- 
enate, was preincubated for 10 min on ice with or without 1 pg/ml 
EGF. The reaction was initiated by adding 20 ~1 containing 5 PCi of 
[r-“P]ATP (final concentration, 1 pM) and Triton X-100 (final 
concentration 0.1%). After 1 or 2 min on ice, the reaction was 
terminated by adding 30 ~1 of SDS-P- mercaptoethanol sample buffer 
and heating to 100 “C for 3 min. After SDS-PAGE on 7% gels, the 
sels were stained. dried, and exnosed to Kodak XAR film. “‘P-0170 
bands on the au&radiographs were quantitated using an LKB iaser 
densitometer. 
To assess EGF-dependent tyrosine-specific kinase activity directed 
toward exogenous substrates, the sythetic peptide RRLIEDAE- 
YAARG was used in an assay modified from Earp et al. (22). Cell 
homogenate (10 ~1) was incubated in a 30-~1 reaction mixture con- 
taining 20 mM PIPES, pH 7.0, 1.0 mM MnC12, 0.1% Triton X-100, 
and 1 iM peptide substrate. An 8-min 30 “C incubation was initiated 
bv addine 20 uM ATP containing 10 uCi of Ir-‘“PlATPlassav. The 
-  -  I  .  .  ~ I  I  
reaction was stopped by adding 15 ~1 of 1 mM ATP in 0.1% bovine 
serum albumin followed by 40 ~1 of 5% trichloroacetic acid. After 20 
min at 0 “C, samples were centrifuged in an Eppendorf microfuge for 
10 min. Aliquots (30 ~1) of supernatant were spotted onto phospho- 
cellulose paper (P-81 Whatman) and washed three times (15 min 
each) with 30% acetic acid and once with acetone. Dried filters were 
counted for Cerenkov radiation. Aliquots from each homogenate were 
assayed in triplicate, and background (assay without peptide) for each 
homogenate was determined in duplicate and subtracted. 
RESULTS 
Suppression of EGF Receptor Autophosphorylation in Ho- 
mogenates of Cells during Endocytosis-Using anti-P-Tyr 
Western blotting techniques, we have noted previously that 
EGF stimulated EGF receptor tyrosine phosphorylation 
within 5 s of addition to intact WB cells. The stimulation was 
maximal between 30 s and 2.5 min but persisted for 15-30 
min (17). When EGF receptor autophosphorylation was ey- 
amined in cell homogenates, receptor autophosphorylation 
was stimulated in cells treated with EGF 15 and 30 min prior 
to homogenization (Figs. 1 and 2). Addition of 1 pg/ml EGF 
to the homogenate assay did not further increase receptor 
autophosphorylation in cells pretreated with EGF for 15-30 
min. As expected, EGF addition to homogenates of cells that 
had not been treated with EGF stimulated receptor phos- 
phorylation. In contrast, homogenates from cells treated with 
EGF in culture for 2.5-5.0 min did not exhibit stimulated 
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FIG. 1. Suppression of EGF receptor autophosphorylation 
by EGF-treatment of cultured cells. Intact WB cells were incu- 
bated without EGF or with EGF (100 rig/ml) for 2.5 or 15 min at 
37 “C. At indicated times, cell monolayers were washed, scraped, and 
homogenized as described under “Experimental Procedures.” A, ali- 
quots-(20 ~1) of each homogenate were incubated without or with 1 
&ml EGF for 10 min at 0 “C and then assaved for EGF recentor 
I .  
autophosphorylation activity as described under “Experimental Pro- 
cedures.“.Gel-electrophoresis and autoradiography were performed. 
The “‘P-~170 region of the autoradioaranh is shown. B. aliauots (50 
I  1  
~1) from the same homogenates assayed for autophosphorylaiion were 
added to 25 ~1 of 3 x SDS-PAGE sample buffer (with 6% P-mercap- 
toethanol) and heated at 100 “C for 3 min. They were electrophoresed 
and analyzed by immunoblotting with anti-P-Tyr, as described under 
“Experimental Procedures.” The 170-kDa band corresponding to 
EGF receptor is shown from the autoradiograph detecting “‘I-protein 
A-labeled anti-P-Tyr antibodies. In this experiment the cultured cells 
were preincubated with 200 jiM sodium vanadate; under these condi- 
tions ~170 retains P-Tyr for greater than 15 min. 
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FIG. 2. Transient suppression of EGF receptor autophos- 
phorylation in homogenates of EGF-treated cells. Triplicate 
sets of WB cells were incubated with or without 100 rig/ml EGF in 
culture at 37 “C for the indicated times. Homogenates were made and 
incubated with (hatched bars) or without (empty bars) 1 rg/ml EGF 
for 10 min at 0 “C and assayed for EGF receptor autophosphorylation. 
“P-p170 (EGF receptor) bands on autoradiographs were quantitated 
by laser densitometry. The brackets represent the standard error of 
the mean. 
EGF receptor autophosphorylation nor were they appreciably 
stimulated by 1 pg/ml EGF added to the assay. Thus, although 
the receptor kinase had been active in autophosphorylation 
during some portion of the 2.5 min after EGF addition (as 
indicated by increased EGF receptor P-Tyr in the immunoblot 
from the intact cell Fig. 1B and Ref. 17), this activity was 
suppressed by the time of the cell-free assay. Immunoblotting 
with anti-rat EGF receptor antibody has demonstrated that 
the amount of immunoidentifiable EGF receptor in the WB 
cell homogenates was equivalent in control cells and at times 
up to 15 min after the addition of EGF to intact cells (17). 
Thus, the differences in autophosphorylation at 2.5-5 min are 
not due to differential recovery of EGF receptor at various 
times during internalization. 
Suppression of autophosphorylation was not detected in 
homogenates of cells treated with EGF in culture for only 30 
s, i.e. preincubation of such homogenates with excess EGF 
lead to activation in the autophosphorylation assay (data not 
shown). Therefore a time-dependent yet transient (-1-5 min) 
suppression of EGF receptor autophosphorylation was ob- 
served in homogenates of cells treated with EGF in culture. 
Maximal suppression typically occurred at 2.5 min. Since lz51- 
EGF binding studies (after acid stripping) of the intact WB 
cells showed that at least 40% of the receptors remained 
accessible at the cell surface after 2.5 min of EGF incubation 
(17), suppression of receptor autophosphorylation (as defined 
by this assay) can occur without internalization of the entire 
receptor population. Although added EGF (1 pg/ml) might 
not be expected to gain access to the EGF binding site within 
the endocytotic vesicle, it could not activate (in homogenates) 
the population of receptors (-40%) that are not yet within an 
enclosed vesicle at 2.5 min. 
Homogenates of cells incubated with EGF in culture for 
15-30 min at 18 “C also showed suppressed autophosphory- 
lation activity, indicating that the suppression time course 
can be slowed at temperatures known to retard receptor 
internalization (Fig. 3). Homogenates of cells incubated with 
EGF for 2 h at 18 “C showed stimulated autophosphorylation 
(Fig. 3). Thus, there appears to be a point in the internaliza- 
tion process at which the autophosphorylation reaction is 
inhibited. The time required to reach this state (and to exit 
from it) varies with temperature. 
Dose Response of EGF Receptor Autophosphorylation 
Suppression-Suppression of EGF receptor autophosphory- 
lation occurred in a dose-dependent manner. Homogenates 
EGF IN 
CULTURE (min) 0 30 120 0 30 120 
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FIG. 3. Effect of 18 “C incubation on suppression of EGF 
receptor autophosphorylation. WB cells were incubated with EGF 
in culture at 18 “C for the indicated times, homogenized, and analyzed 
for EGF receptor autophosphorylation. The ~170 region of the auto- 
radiograph is shown. 
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FIG. 4. Dose respons F receptor autophosphorylation 
suppression. WB cells were incubated for 2.5 min at 37 “C with the 
indicated amounts of EGF, homogenized, incubated with or without 
1 pg/ml EGF for 10 min at 0 “C, and assayed for EGF receptor 
autophosphorylation as described under “Experimental procedures.” 
were prepared from WB cells which had been incubated for 
2.5 min at 37 “C! at EGF concentrations ranging from 0.5 to 
1000 rig/ml. Each sample showed only basal levels of EGF 
receptor autophosphorylation activity without preincubatioii 
with excess EGF prior to assay (Fig. 4). Preincubation of 
these homogenates with 1 pg/ml EGF for 10 min at 0 “C prior 
to the autophosphorylation assay stimulated EGF receptor 
autophosphorylation if the EGF dose in culture had been 10 
rig/ml or less. From 30 to 1000 rig/ml EGF there was a dose- 
dependent decrease in the ability to respond to added EGF in 
the homogenate autophosphorylation assay (Fig. 4). This 
suggests that only occupied receptors undergoing internali- 
zation enter the suppressed state, whereas the unoccupied 
receptors remaining at the surface behave like those in cells 
that were not treated with EGF. 
The Relationship between EGF Receptor P-Tyr Content and 
Autophosphorylation Actiuity-P-Tyr Western blotting dem- 
onstrates a dramatic increase in EGF receptor P-Tyr content 
within 5 s of adding EGF to intact WB cells. Maximal P-Tyr 
levels persist for 2.5-5 min and decrease by 62% at 15 min 
(17). We examined whether the transient early suppression 
could be ascribed to occupancy of receptor autophosphoryla- 
tion sites by unlabeled phosphate from cellular ATP. 
Initially, cells were incubated with EGF under conditions 
which inhibited the loss of P-Tyr from EGF receptor. Inhi- 
bition of tyrosine phosphatases (23) by 200 ~.LM vanadate 
prevented the loss of EGF receptor P-Tyr between 2.5 and 15 
min of EGF treatment, as assessed by P-Tyr Western blots 
(e.g. Fig. 1B). However, homogenates of vanadate-treated cells 
still exhibited the same pattern of transient suppression fol- 
lowed by stimulation of autophosphorylation (Fig. IA). Like- 
wise, incubation of cells in the presence of 10 mM methyla- 
mine, which inhibits endosome acidification, inhibited the 
loss of P-Tyr from EGF receptor assessed in whole cell lysates 
between 2.5 and 15 min (17). Again, the suppression/activa- 
tion pattern of EGF receptor autophosphorylation in the 
homogenates of methylamine-treated cells was maintained 
(data not shown). Thus, maintenance of EGF receptor P-Tyr 
in the intact cell for 15 min by vanadate or methylamine did 
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not prolong the suppressed state to 15 min. 
Since the homogenization for the cell-free assay was done 
in the absence of phosphatase inhibitors, EGF receptor P- 
Tyr may have been lost prior to the cell-free assay. Compar- 
ison of EGF receptor P-Tyr content in homogenates of EGF- 
treated cells with the content in rapidly prepared radioim- 
mune precipitation buffer lysates (both assessed by anti-P- 
Tyr immunoblots) showed an 84 f 4% (n = 3) loss of EGF 
receptor P-Tyr under the standard homogenizing conditions. 
Thus, during preparation for the cell-free assay, virtually all 
the receptor P-Tyr was lost, yet decreased autophosphoryla- 
tion occurred. This clearly indicates that suppression is not 
due to occupation of autophosphorylation sites. 
The suppressed autophosphorylation in homogenates of 
cells treated for 2.5 min with EGF could be reversed by an 
incubation at 30 “C (Fig. 5A). If the 30 “C incubation was 
performed in the absence of vanadate, dephosphorylation of 
the 15-20% of the receptors that still contained P-Tyr oc- 
curred. The 30 “C incubation restored the ability of EGF (1 
pg/ml) to stimulate receptor autophosphorylation. Restora- 
tion of autophosphorylation did not occur if the lo-min in- 
cubation was performed at 0 “C (first two lanes in Fig. 5A). 
The addition of 500 FM vanadate to the homogenate prevented 
loss of P-Tyr from EGF receptor during the lo-min 30 “C 
preincubation (Fig. 5B), but did not prevent the return of the 
ability of EGF to stimulate autophosphorylation (Fig. 5A). 
Thus, a temperature-dependent event(s) other than EGF 
receptor tyrosine dephosphorylation was responsible for re- 
turning the receptor to an activatable state. 
Effect of Protein Kinase C Activation on Suppression of 
Homogenate EGF Receptor Autophosphorylation-Since oth- 
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FIG. j. Effect of preincubation of homogenates at 30 “C on 
EGF receptor autophosphorylation suppression and EGF 
receptor P-Tyr content. A, homogenates were prepared from un- 
treated cells or EGF-treated cells (100 rig/ml for 2.5 min at 37 “C) as 
described under “Experimental Procedures.” Aliquots (20 ~1) of each 
homogenate were incubated for 10 min at 0 “C, or at 30 “C with or 
without 500 MM sodium vanadate (V), as indicated. The aliquots were 
then incubated with or without 1 @g/ml EGF for 10 min at 0 “C and 
assayed for EGF receptor autophosphorylation as described under 
“Experimental Procedures.” B, an aliquot (50 ~1) of the untreated cell 
homogenate (left lane) and aliquots of the EGF-treated cell homoge- 
nate (right three lanes) described above were incubated for 10 min at 
0 or 30 “C without or with BOO pM sodium vanadate (V), as indicated. 
They were then incubated for an additional 10 min at 0 “C. SDS- 
PAGE sample buffer (25 ~1) was added, the samples were heated to 
100 “C for 3 min, and the samples were analyzed for tyrosine phos- 
phoproteins by immunohlotting with anti-P-Tyr as described under 
“Experimental Procedures.” The 170.kDa hand corresponding to 
EGF receptor is shown. 
ers had detected or postulated protein kinase C-dependent 
decreases in EGF receptor autophosphorylation in A431 cells 
(10, 16), we investigated the possibility that a protein kinase 
C-catalyzed event was responsible for the suppression meas- 
ured in cell-free extracts of WB cells. Cells were preincubated 
for 18 h with 10 pM TPA. This treatment results in both 
depletion of >95% of the protein kinase C activity in these 
cells and abolition of the ability of TPA to inhibit hormone- 
stimulated activation of phospholipase C (15). Subsequently 
all cells were treated with EGF for the indicated times, ho- 
mogenized, and subjected to the cell-free autophosphorylation 
assay. The temporal pattern of autophosphorylation activity 
in protein kinase C-depleted cells (Fig. 6, C and D) was almost 
identical to that of untreated cells (Fig. 6, A and B), suggesting 
that protein kinase C is not involved in the early suppression 
of autophosphorylation activity measured under these condi- 
tions. Peak autophosphorylation activity was slightly greater 
in TPA-treated cells. This is consistent with increases in 
surface EGF binding that we and others have noted following 
long-term TPA treatment (24, 25). Conversely, we tested the 
direct effect of TPA by incubating WB cells for 2.5-15 min 
with or without 100 nM TPA. At these early time points (2.5- 
15 min), TPA did not appreciably alter receptor autophos- 
phorylation measured in the cell-free assay (Fig. 7 and Table 
I). ““I-EGF binding studies demonstrated that 100 nM TPA 
EGF IN TPA PRE- 
ASSAY TREATMENT TIME WITH EGF (min) __~ 
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FIG. 6. Depletion of protein kinase C by overnight TPA 
pretreatment does not alter EGF-induced suppression of EGF 
receptor autophosphorylation. All cells were incubated with 100 
rig/ml EGF at 37 “C for the indicated time periods, homogenized, 
aliquots incubated without (A and C) or with added EGF (1 pg/ml) 
(B and II), and assayed for EGF receptor autophosphorylation. The 
cells used in C and D had been preincuhated for 18 h with 10 /rM 
TPA in culture, a treatment that depletes >95% of the protein kinase 
C activity. 
Time of TPA 
Pretreatment (min) C 2.5 5.0 IO 15 
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FIG. 7. Preincubation with TPA does not produce suppres- 
sion of EGF receptor autophosphorylation. WB cell were incu- 
hated without or with 100 nM TPA at 37 “C for the indicated times 
prior to homogenization and phosphorylation as described under 
“Experimental Procedures.” The addition of TPA did not signifi- 
cantly alter EGF-dependent homogenate EGF receptor autophos- 
phorylation at times at which EGF results in suppressed autophos- 
phorylation. TPA did alter EGF receptor metabolism within this time 
frame as shown by decreases in ““I-EGF binding. 
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TABLE I 
Effect of TPA and angiotensin on subsequent EGF-dependent 
autophosphorylation in homogenates 
Intact WB cells were incubated with the indicated concentration 
of TPA or Angiotensin II for the indicated time at 37 “C. Homoge- 
nates were prepared and phosphorylated in the presence or absence 
of 1 pg/ml EGF and subjected to SDS-PAGE as described under 
“Experimental Procedures.” Densitometric analysis of “‘P-p170 was 
performed and the fold increase obtained by dividing the extent of 
autophosphorylation in the presence of EGF by the value in the 
absence of EGF. The values, except for the 5-min TPA time point, 
are the averages of two separate experiments. 
Fold increase in EGF receptor 
autophosphorylation stimulated by EGF 
Time of 
pretreatment Cells treated with 
TPA (100 nM) 











2.5 4.2 4.5 
5 3.0 4.0 
10 4.9 3.9 
15 4.3 
decreased surface binding within this time frame (data not 
shown). However, to more precisely mimic the physiologic 
EGF-dependent activation of protein kinase C, WB cells were 
pretreated with angiotensin II. This agent activates phospho- 
lipase C in WB cells, generating endogenous inositol phos- 
phates and presumably diacylglycerol within 5-30 s (15). 
Angiotensin decreases lz51-EGF binding within 5 min (data 
not shown), but EGF receptor autophosphorylation in ho- 
mogenates was unaffected by pretreatment with angiotensin 
for 45 s to 10 min (Table I). It should be noted that no steps 
were taken to preserve EGF receptor Thr-654 phosphoryla- 
tion, a protein kinase C-dependent phosphorylation known 
to inhibit EGF-dependent EGF receptor tyrosine kinase ac- 
tivity. Thus, the above only demonstrate that protein kinase 
C is not responsible for the phenomenon studied in this cell- 
free assay. 
Suppressed Phosphorylation of Exogenous Substrate-To 
test whether EGF-R/kinase activity toward exogenous sub- 
strates showed an EGF-dependent suppression/activation 
profile similar to that of autophosphorylation, homogenates 
of EGF-treated cells were assayed for their ability to phos- 
phorylate the synthetic peptide from the region around a 
major pp60src autophosphorylation site, RRLIEDAE- 
YAARG. The cumulative results of three separate experi- 
ments are shown in Fig. 8. Peptide phosphorylation was 
observed over basal levels in homogenates of cells treated for 
5 min with EGF. However, the activity increased further in 
homogenates of cells treated with EGF for 15 min. The 
activity declined slightly in homogenates of cells treated for 
30 min with EGF and dropped to below basal levels in ho- 
mogenates of cells incubated with EGF for 120 min; this 
decline correlates with receptor degradation (17). Homoge- 
nates of cells incubated with EGF at 18 “C showed a Z-fold 
increase in peptide phosphorylation at 30 min, increasing to 
C-fold by 120 min (Fig. 8). Although there was some increase 
over basal at the early times, it should be noted that the 
peptide phosphorylation assay unlike the autophosphoryla- 
tion assay requires a 30 “C incubation and a 30 “C incubation 
is capable of reactivating EGF receptor autophosphorylation 
(see Fig. 5). Thus, although the suppression of exogenous 
substrates phosphorylation after EGF treatment (5 min at 
37 “C or 30 min at 18 “C) is not as complete as that measured 
FIG. 8. EGF-dependent tyrosine phosphorylation of an ex- 
ogenous peptide substrate. Homogenates were incubated for 8 min 
at 30 “C with the peptide substrates as described under “Experimental 
Procedures.” Samples were obtained from untreated cells (zero time) 
or cells treated for the indicated times with 100 rig/ml EGF at 37 “C 
(A) or at 18 “C (B). The mean from three separate experiments at 
each time point is shown and is compared with the basal activity for 
that assay. The brackets represent the standard errors of the mean of 
the three experiments. Although the receptor had been fully active in 
the intact cell (see Fig. 1 and Ref. 17 for P-Tyr immunoblots of cell 
lysates), the kinase activity of the earlier time points (5 min at 37 “C, 
30 min at 18 “C) was below that of late time points. This pattern 
correlates qualitatively with the pattern of suppression and relief of 
suppression measured in the EGF receptor autophosphorylation as- 
say. 
by the autophosphorylation assay (see Figs. l-4), the kinase 
activity is still clearly below that of the later time points. 
Since nothing was done to these cells other than allowing 
endocytosis to proceed for prolonged periods, the best expla- 
nation for the subsequent increase in kinase activity is the 
relief of suppression. The timing of the relief of suppression 
in both assays is parallel at both 37 and 18 “C. 
DISCUSSION 
EGF receptor autophosphorylation activity in a cell-free 
assay was suppressed in homogenates of cultured rat liver 
epithelial cells incubated with EGF for short periods of time 
(2.5-5 min). This suppression was followed by a 3- to 6-fold 
increase in autophosphorylation activity after 15-30 min of 
EGF incubation (e.g. Figs. 2 and 6). This suppression in the 
homogenate assay needs to be interpreted in the light of the 
fact that EGF-dependent stimulation of substrate tyrosine 
phosphorylation (assessed by immunoblotting) is maximal 
within 15-30 s of exposure to EGF and that EGF receptor P- 
Tyr content remains elevated for 2-5 min and then declines 
(17). Our initial interpretation was that the lack of [32P]ATP 
labeling of the receptor in the cell-free assay was due to 
autophosphorylation site occupancy. However, incubation 
conditions in culture that inhibited tyrosine dephosphoryla- 
tion (vanadate or methylamine) failed to maintain the sup- 
pressed state of the receptor. In addition, measurement of 
EGF receptor P-Tyr remaining after preparation for the cell- 
free autophosphorylation assay demonstrated >85% loss 
receptor P-Tyr. These and other experiments (Fig. 5) dem- 
onstrate that suppression of kinase activity could not be 
explained by EGF receptor P-Tyr occupancy. 
We next investigated the potential role of protein kinase 
C-catalyzed phosphorylation of the EGF receptor (7-10). EGF 
stimulates phospholipase C activity in WB and A431 cells 
and leads to Thr-654 phosphorylation in A431 cells (13, 15). 
A 5-min treatment of WB cells with TPA is capable of 
decreasing EGF-dependent phospholipase C y-tyrosine phos- 
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phorylation.’ However, depletion of protein kinase C by pro- 
longed incubation of WB cells with 10 pM TPA had no effect 
on the suppression of EGF receptor autophosphorylation in 
the cell-free assay. Moreover, the addition of TPA or angio- 
tensin II prior to homogenization did not suppress autophos- 
phorylation measured under these assay conditions. Thus, 
protein kinase C is not responsible for the phenomenon under 
study in this report. These findings are different from those 
of Chinkers and Garbers (lo), who described near-maximal 
EGF-dependent suppression of EGF receptor/kinase activity 
in partially purified receptor preparations from A431 cells. 
Their effect could be seen when only a small portion of 
available EGF receptors were occupied. (In WB cells high 
concentrations of EGF were required, Fig. 4.) They suggested 
that protein kinase C suppressed EGF receptor autophos- 
phorylation. One major difference between our study and 
those noted above is the cell type used. Receptor internaliza- 
tion is inefficient in A431 cells (16), and EGF receptor auto- 
phosphorylation is maintained for up to 6 h, presumably due 
to the persistence of cell surface receptors (16). In WB cells, 
at the high dose of EGF at which suppression is observed, the 
receptor is >90% cleared from the surface by 15 min. In 
addition our cell-free assay are different from that used by 
Chinkers and Garbers (10) in A431 cells. Using our methods, 
neither angiotensin II nor TPA provoke the same type of 
suppressed autophosphorylation that is induced by EGF in 
WB cells. This again indicates that protein kinase C is not 
involved. 
The suppressed state in WB cells at 2.5-5 min cannot be 
overcome by adding EGF to the cell-free assay. This could be 
due in part to enclosure of EGF binding sites within vesicles. 
However, this inaccessibility of binding site to added EGF 
does not obviate the finding of suppression. The EGF receptor 
internalized after a 15 min EGF treatment is quite active 
without added EGF. EGF present within the endocytotic 
vesicle at 15 min is sufficient, under these conditions, to 
sustain full activity, provided the receptor is in a state in 
which it can be activated; this is not the case at 2.5-5 min. 
Since all autophosphorylation assays were initiated in the 
presence of detergent, it is unlikely that differences in the 
sealing of the vesicles explains the difference in homogenates 
from cells 2.5 or 15 min after EGF addition to intact cell (see 
Ref. 17 for a detailed assessment of the effect of detergent on 
EGF receptor autophosphorylation in WB cell homogenates). 
The question arises as to whether suppression is only seen 
with analysis of autophosphorylation or whether it can be 
detected using an exogenous substrate assay. Fig. 8 shows 
that exogenous substrate phosphorylation is also suppressed 
at times similar to those in which autophosphorylation is 
suppressed. EGF-R/kinase activity toward exogenous sub- 
strates is somewhat higher when compared with the near total 
suppression of autophosphorylation. Activity is modestly in- 
creased in homogenates of 5-min EGF-treated cells, but pro- 
gresses to peak activity in homogenates of cells treated with 
EGF for 15 min. Similarly, in incubations carried out at 18 “C, 
the increase in exogenous peptide phosphorylation at 30 min 
(when autophosphorylation is suppressed, see Fig. 3) is only 
one-third of the increase observed at 120 min (when auto- 
phosphorylation is also greatly stimulated), even though 
receptor internalization is virtually complete by 30 min (17). 
Thus, exogenous peptide phosphorylation at times of sup- 
pressed autophosphorylation is clearly less than the increase 
observed at times of stimulated autophosphorylation. One 
particular difference in the autophosphorylation and peptide 
phosphorylation assays may account for modest activity noted 
in the peptide phosphorylation at early time points. The 
peptide assay is carried out at 30 “C, a temperature at which 
we have observed loss of autophosphorylation suppression. 
Thus, slightly higher level of peptide phosphorylation (com- 
pared with autophosphorylation) may be due to “desuppres- 
sion” of a receptor activity inherent in the 30 “C assay con- 
ditions. In addition, the peptide assay would be sensitive to 
the activities of other tyrosine kinases activated indirectly by 
the action of EGF on intact cells; these activities would not 
be detected in the autophosphorylation assay. 
At least three other mechanisms for suppressed autophos- 
phorylation merit consideration: (i) activation of a serine/ 
threonine protein kinase, (ii) a conformational change in the 
receptor which inhibits autophosphorylation, or (iii) an asso- 
ciation with elements of the internalization pathway, e.g. 
clathrin or the cytoskeleton, that inhibit autophosphoryla- 
tion. EGF-dependent activation of a serinelthreonine kinase 
other than protein kinase C clearly occurs. EGF treatment of 
intact WB cells resulted in the appearance of a new phospho- 
protein, ~280, when homogenates are phosphorylated in the 
presence of [y-32P]ATP (see Fig. 5A in this paper and Fig. 3 
in Ref. 17). Phosphoamino acid analysis demonstrated that 
~280 is phosphorylated on threonine residues.3 Stimulation 
of ~280 phosphorylation in homogenates is only seen when 
EGF is added to intact cells at least 30-60 s before homoge- 
nization; addition of EGF to control cell homogenates does 
not stimulate ~280 phosphorylation. Moreover, EGF treat- 
ment initiates ~280 homogenate phosphorylation in cells de- 
pleted of >95% of their protein kinase C activity.3 This 
indicates that EGF can activate a serine/threonine kinase in 
these cells in addition to protein kinase C and may indicate 
that EGF can activate a kinase in WB cells similar to the 
microtubule-associated protein 2 kinase (26, 27). The most 
compelling argument against the involvement of a novel 
serine/threonine kinase is the high dose of EGF (30-1000 ng/ 
ml) required to obtain suppression (Fig. 4). This suggests that 
suppression is related to individual receptor occupancy. Thus, 
a novel kinase would seem to be involved only if the EGF 
receptor had to be occupied by EGF to be a substrate. 
A second possibility is that, in intact cells, EGF induces a 
series of conformational changes in the EGF receptor result- 
ing in kinase activation followed by transient suppression. 
EGF-induced receptor oligimerization in intact cells has been 
demonstrated (4, 5) and is a mechanism postulated either to 
activate EGF receptor/kinase (l-3) or to reduce kinase activ- 
ity (28). In addition, DiPaolo and Maxfield (29) have pre- 
sented evidence that the acidic environment of the endosome 
may cause a conformational change in the EGF receptor. The 
EGF-dependent suppression of detectable kinase activity dur- 
ing internalization could be due to a transient alteration in 
the oligomeric state of receptor. As endocytosis proceeds (or 
during a 30 “C incubation of homogenates, see Fig. 5), the 
internalized receptor may once again be restored to a state in 
which autophosphorylation is detectable. 
The third possibility is that suppression is related to a time- 
and dose-dependent association of receptor with structural 
elements of the endocytotic pathway. Perhaps the mobility of 
the EGF receptor/kinase is sterically hindered by components 
of the nascent endosomes such as clathrin polymers or cyto- 
skeletal components which form about the cytoplasmic sur- 
face of the plasma membrane and persist around the cyto- 
plasmic surface of early endosomes (30). Movement into the 
coated vesicles and associated elements in the first 2-5 min 
could even cause suppression of receptors whose binding 
domains are still external to the cell but whose cytoplasmic 
‘B. K. McCune, R. C. Dy, C. A. Prokop, and H. S. Earp, unpub- 
lished results. 
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domains are enmeshed in the forming vesicle. An association 
of the receptor with cytoskeletal elements has been postulated 
by Landreth and co-workers (31) who detected a more stable 
association of the EGF receptor with a Triton-insoluble frac- 
tion after the addition of EGF to A431 cells. The massive 
overexpression of EGF receptor in A431 and the attendant 
inefficient entry into the degradation pathway may explain a 
more prolonged association with the cytoskeleton in A431 
cells. In WB cells, the association with the subsurface network 
may be terminated as the endosome moves away from the 
plasma membrane. This movement may relieve the suppres- 
sion. 
Our results do not establish a physiological role for the 
observed suppression nor do they prove that the kinase under- 
goes transient suppression in the intact cell. However, our 
results do clearly indicate that some biochemical change in 
the receptor’s kinase activity occurs at defined times during 
internalization; this change is reversed as endocytosis pro- 
ceeds. The phenomenon is not due to occupation of auto- 
phosphorylation sites nor is it mediated by protein kinase C. 
It remains to be determined whether the suppression is 
causally related to the observation that the majority of sub- 
strates detectable by P-Tyr immunoblots of intact WB cells 
are phosphorylated during the first 5-60 s of EGF action (17), 
a time prior to the onset of detectable suppression. 
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